Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Thymosin Beta-4
TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide found in virtually all human and animal cells. It plays a crucial role in tissue repair, cell migration, and reduction of inflammation.
TB-500 promotes cell migration by binding to and sequestering actin, a key structural protein. It also promotes angiogenesis and reduces pro-inflammatory cytokines, facilitating tissue repair.
Animal studies show significant benefits in wound healing, cardiac repair post-infarction, and corneal repair. Clinical trials are limited. TB-500 has been used extensively in equine veterinary medicine for injury recovery.
Typical Dose
2.5mg
Range
2-5mg
Frequency
2x/week (subcutaneous)
Route
SubQ or IM
Duration
4-8 weeks
Reconstitution
5mg vial + 1mL bacteriostatic water = 5,000mcg/mL
Notes
Loading phase of 2x/week for 4–6 weeks is typical, followed by a maintenance dose of once weekly. Can be injected anywhere subcutaneously.
These biomarkers are commonly tracked to assess response and safety. Run baseline labs before starting, mid-cycle labs halfway through, and post-cycle labs 1–2 weeks after the final dose.
Build a protocol with TB-500, schedule blood work for key biomarkers, and track your results.
Build Protocol with TB-500This platform provides informational tools only, not medical advice. This information is for educational purposes only. Consult a licensed provider.